• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤 DDR1 促进胶原纤维排列以引发免疫排斥。

Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion.

机构信息

Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.

Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.

出版信息

Nature. 2021 Nov;599(7886):673-678. doi: 10.1038/s41586-021-04057-2. Epub 2021 Nov 3.

DOI:10.1038/s41586-021-04057-2
PMID:34732895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8839149/
Abstract

Immune exclusion predicts poor patient outcomes in multiple malignancies, including triple-negative breast cancer (TNBC). The extracellular matrix (ECM) contributes to immune exclusion. However, strategies to reduce ECM abundance are largely ineffective or generate undesired outcomes. Here we show that discoidin domain receptor 1 (DDR1), a collagen receptor with tyrosine kinase activity, instigates immune exclusion by promoting collagen fibre alignment. Ablation of Ddr1 in tumours promotes the intratumoral penetration of T cells and obliterates tumour growth in mouse models of TNBC. Supporting this finding, in human TNBC the expression of DDR1 negatively correlates with the intratumoral abundance of anti-tumour T cells. The DDR1 extracellular domain (DDR1-ECD), but not its intracellular kinase domain, is required for immune exclusion. Membrane-untethered DDR1-ECD is sufficient to rescue the growth of Ddr1-knockout tumours in immunocompetent hosts. Mechanistically, the binding of DDR1-ECD to collagen enforces aligned collagen fibres and obstructs immune infiltration. ECD-neutralizing antibodies disrupt collagen fibre alignment, mitigate immune exclusion and inhibit tumour growth in immunocompetent hosts. Together, our findings identify a mechanism for immune exclusion and suggest an immunotherapeutic target for increasing immune accessibility through reconfiguration of the tumour ECM.

摘要

免疫排斥预测多种恶性肿瘤(包括三阴性乳腺癌 [TNBC])患者预后不良。细胞外基质(ECM)有助于免疫排斥。然而,减少 ECM 丰度的策略在很大程度上是无效的或产生不良后果。在这里,我们表明具有酪氨酸激酶活性的胶原受体 discoidin 域受体 1(DDR1)通过促进胶原纤维排列引发免疫排斥。在肿瘤中敲除 Ddr1 可促进 T 细胞在肿瘤内的浸润,并在 TNBC 的小鼠模型中消除肿瘤生长。支持这一发现,在人类 TNBC 中,DDR1 的表达与肿瘤内抗肿瘤 T 细胞的丰度呈负相关。DDR1 的细胞外结构域(DDR1-ECD),而不是其细胞内激酶结构域,是免疫排斥所必需的。膜非束缚的 DDR1-ECD 足以挽救 DDR1 敲除肿瘤在免疫活性宿主中的生长。从机制上讲,DDR1-ECD 与胶原的结合强制形成排列整齐的胶原纤维,并阻碍免疫浸润。ECD 中和抗体破坏胶原纤维排列,减轻免疫排斥并抑制免疫活性宿主中的肿瘤生长。总之,我们的研究结果确定了一种免疫排斥的机制,并提出了一种通过重新配置肿瘤 ECM 来增加免疫可及性的免疫治疗靶标。

相似文献

1
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion.肿瘤 DDR1 促进胶原纤维排列以引发免疫排斥。
Nature. 2021 Nov;599(7886):673-678. doi: 10.1038/s41586-021-04057-2. Epub 2021 Nov 3.
2
A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer.一种高选择性的人源化 DDR1 mAb 通过破坏乳腺癌中胶原纤维的排列来逆转免疫排斥。
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2023-006720.
3
DDR1 promotes breast tumor growth by suppressing antitumor immunity.DDR1 通过抑制抗肿瘤免疫促进乳腺癌生长。
Oncol Rep. 2019 Dec;42(6):2844-2854. doi: 10.3892/or.2019.7338. Epub 2019 Sep 27.
4
Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.肿瘤外在盘状结构域受体 1 通过调节小鼠脂肪基质白细胞介素 6 的产生促进乳腺肿瘤生长。
J Biol Chem. 2018 Feb 23;293(8):2841-2849. doi: 10.1074/jbc.RA117.000672. Epub 2018 Jan 3.
5
Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1-Mediated Resistant Colorectal Cancer Therapy.克服肿瘤胶原障碍:一种用于 DDR1 介导的耐药结直肠癌治疗的多阶段药物递送策略。
Adv Sci (Weinh). 2024 Sep;11(33):e2402107. doi: 10.1002/advs.202402107. Epub 2024 Jul 2.
6
Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.盘状结构域受体1激酶活性是调节IV型胶原合成所必需的。
Matrix Biol. 2017 Jan;57-58:258-271. doi: 10.1016/j.matbio.2016.11.009. Epub 2016 Dec 1.
7
Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.Discoidin domain receptor 1 激活将细胞外基质与 Alport 综合征中足细胞的脂毒性联系起来。
EBioMedicine. 2021 Jan;63:103162. doi: 10.1016/j.ebiom.2020.103162. Epub 2020 Dec 16.
8
DDR1 (Discoidin Domain Receptor-1)-RhoA (Ras Homolog Family Member A) Axis Senses Matrix Stiffness to Promote Vascular Calcification.DDR1(盘状结构域受体 1)-RhoA(Ras 同源家族成员 A)轴感知基质硬度以促进血管钙化。
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1763-1776. doi: 10.1161/ATVBAHA.120.314697. Epub 2020 Jun 4.
9
Diabetic Vascular Calcification Mediated by the Collagen Receptor Discoidin Domain Receptor 1 via the Phosphoinositide 3-Kinase/Akt/Runt-Related Transcription Factor 2 Signaling Axis.糖尿病血管钙化通过胶原蛋白受体盘状结构域受体 1 介导的磷酸肌醇 3-激酶/蛋白激酶 B/成视网膜细胞瘤相关转录因子 2 信号轴。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1878-1889. doi: 10.1161/ATVBAHA.118.311238.
10
Collagen Fibril Ultrastructure in Mice Lacking Discoidin Domain Receptor 1.缺乏盘状结构域受体1的小鼠中的胶原纤维超微结构
Microsc Microanal. 2016 Jun;22(3):599-611. doi: 10.1017/S1431927616000787.

引用本文的文献

1
Targeting collagen in "armored and cold" tumors: Overcoming barriers to cancer therapy.靶向“坚硬且冷”肿瘤中的胶原蛋白:克服癌症治疗障碍
Cancer Pathog Ther. 2024 Nov 30;3(5):383-391. doi: 10.1016/j.cpt.2024.11.001. eCollection 2025 Sep.
2
Modulating tumor collagen fiber alignment for enhanced lung cancer immunotherapy via inhaled RNA.通过吸入RNA调节肿瘤胶原纤维排列以增强肺癌免疫治疗
Nat Commun. 2025 Aug 30;16(1):8120. doi: 10.1038/s41467-025-63415-0.
3
DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ductal Adenocarcinoma.
DDR1驱动胶原蛋白重塑和免疫排斥:胰腺癌的泛癌见解与治疗靶点
Int J Mol Sci. 2025 Aug 10;26(16):7731. doi: 10.3390/ijms26167731.
4
Biomechanics of the tumor extracellular matrix and regulatory T cells: regulatory mechanisms and potential therapeutic targets.肿瘤细胞外基质与调节性T细胞的生物力学:调节机制与潜在治疗靶点
Cell Commun Signal. 2025 Aug 21;23(1):375. doi: 10.1186/s12964-025-02380-z.
5
Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review).人类恶性肿瘤中的癌症相关成纤维细胞,尤其侧重于肉瘤(综述)
Int J Oncol. 2025 Oct;67(4). doi: 10.3892/ijo.2025.5785. Epub 2025 Aug 8.
6
Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation.时钟通路抑制剂通过调节纤维细胞分化克服肿瘤免疫排斥。
NPJ Precis Oncol. 2025 Aug 5;9(1):274. doi: 10.1038/s41698-025-01066-6.
7
Targeting collagen to optimize cancer immunotherapy.靶向胶原蛋白以优化癌症免疫疗法。
Exp Hematol Oncol. 2025 Jul 29;14(1):101. doi: 10.1186/s40164-025-00691-y.
8
Ubiquitin-specific protease 7-mediated stabilization of discoidin domain receptor 1 drives progression of TP53-Mutant cancers.泛素特异性蛋白酶7介导的盘状结构域受体1的稳定促进TP53突变型癌症的进展。
J Biol Chem. 2025 Jul 24;301(9):110515. doi: 10.1016/j.jbc.2025.110515.
9
Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer.巨吞饮作用在胰腺癌的代谢应激下维持癌症相关成纤维细胞(CAF)亚型的特性。
Cancer Cell. 2025 Jul 15. doi: 10.1016/j.ccell.2025.06.021.
10
Collagen in pituitary adenomas: A comprehensive review of biological roles and clinical implications.垂体腺瘤中的胶原蛋白:生物学作用与临床意义的全面综述
J Clin Transl Endocrinol. 2025 Jul 10;41:100408. doi: 10.1016/j.jcte.2025.100408. eCollection 2025 Sep.